Stay updated on Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays a new revision label 'Revision: v3.5.4', replacing the previous 'Revision: v3.5.3', indicating an updated study protocol and statistical plan document.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site/UI release rather than any change to the clinical study details.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

- Check85 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. The prior revision v3.4.2 was replaced.SummaryDifference0.1%

- Check113 days agoChange DetectedRevision tag updated to v3.4.2 and the prior funding-status notice (including the older revision v3.4.1) was removed. No study details, eligibility criteria, endpoints, or results information were modified.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page.